Morty Shulman goes to battle again

Article Abstract:

Mississauga, Ontario-based Draxis Health Inc. founder Morton Shulman seeks his share of the US$41-million deal between Draxis and Pfizer Animal Health Inc., a unit of New York-based Pfizer Inc. The agreement allows Pfizer to market Anipryl, a drug used to treat neurological disorders such as excessive thirst, frequent urination and senility in dogs. Along with Hungarian pharmacologist Jozsef Knoll, Shulman claims he is a co-inventor of Anipryl, which is awaiting approval from the US Food and Drug Administration. Draxis is the former Deprenyl Research Ltd.

Comment:

Founder Morton Shulman seeks his share of the US$41-mil deal between Draxis and Pfizer Animal Health Inc, a unit of Pfizer

Electromedical and Electrotherapeutic Apparatus Manufacturing, Strategic alliances, Neurological & Muscle Stimulators, Article, Draxis Health Inc.

---

Court likely to name Med-Chem receiver

Article Abstract:

Ontario-based Med-Chem Health Care Ltd expects that it will be granted a receivership on Feb 1, 1999, a move that will allow the sale of its medical laboratory operations. The company has had problems since late 1998 in restructuring a debt of $82 million to meet bankruptcy court requirements under the Companies' Creditors Arrangement Act that would have given clearance to continue operations as a smaller business.

Organizational history, Medical Laboratories, Medical and Diagnostic Laboratories, Biomedical laboratories, Med-Chem Health Care Ltd.

---

Similar abstracts:

• Abstracts: ClubLink acquires land for new golf courses. Med-Chem lenders demand repayment of $40-million. Condos at crossroads?
• Abstracts: Cash the focus for new Philip saviour. Raider Carl Icahn buys 9% of Philip. Philip agrees to stop drawing on line of credit
• Abstracts: Bouchard backtracks on bid for Provigo. Provigo board says bid is fair. Provigo plans overhaul of stores
• Abstracts: Centrefund to purchase 10 shopping centres. Cobequid puts faith in DNA vaccine
• Abstracts: Talisman bids for Arakis Energy. Amber begins to fight takeover bid

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.